Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
7:30 AM - HLTH 2025
18
19
20
22
23
24
25
26
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
TigerConnect + eVideon Unite Healthcare Communications
2025-09-30    
10:00 am
TigerConnect’s acquisition of eVideon represents a significant step forward in our mission to unify healthcare communications. By combining smart room technology with advanced clinical collaboration [...]
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
AHIMA25  Conference
2025-10-12 - 2025-10-14    
9:00 am - 10:00 pm
Register for AHIMA25  Conference Today! HI professionals—Minneapolis is calling! Join us October 12-14 for AHIMA25 Conference, the must-attend HI event of the year. In a city known for its booming [...]
HLTH 2025
2025-10-17 - 2025-10-22    
7:30 am - 12:00 pm
One of the top healthcare innovation events that brings together healthcare startups, investors, and other healthcare innovators. This is comparable to say an investor and [...]
Federal EHR Annual Summit
2025-10-21 - 2025-10-23    
9:00 am - 10:00 pm
The Federal Electronic Health Record Modernization (FEHRM) office brings together clinical staff from the Department of Defense, Department of Veterans Affairs, Department of Homeland Security’s [...]
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Events on 2025-10-05
Events on 2025-10-12
AHIMA25  Conference
12 Oct 25
Minnesota
Events on 2025-10-17
HLTH 2025
17 Oct 25
Nevada
Events on 2025-10-21
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN

Events

Latest News

Keep Emerson (EMR) in Your Portfolio: Here’s Why

Emerson Electric Co is experiencing robust demand across multiple sectors, especially in process and hybrid markets, which is propelling its order growth. Management foresees sustained strong sales in these markets throughout fiscal 2024, driven by the resilience of chemical, life sciences, LNG, metals and mining, and sustainability and decarbonization sectors.

In the Intelligent Devices segment, Emerson is observing strong performance in measurement and analytical, as well as final control businesses, supported by demand in hybrid and process markets. With optimism prevailing across its segments, Emerson anticipates a 12.5-14.5% surge in net sales for the second quarter of fiscal 2024 compared to the prior year.

Emerson is actively pursuing expansion through acquisitions. Recent acquisitions such as Afag and Flexim have bolstered its capabilities in factory automation, battery manufacturing, automotive, electronics, and automation portfolio. Additionally, the acquisition of National Instruments has strengthened its footprint in semiconductor, electronics, transportation, electric vehicles, and aerospace & defense sectors.

The company is committed to enhancing shareholder value through dividends and share repurchases. In the first quarter of fiscal 2024, it disbursed dividends totaling $300 million and repurchased common stocks worth $175 million. Furthermore, Emerson raised its dividend by 1% in October 2023.
User

However, EMR has noted a decline in performance within its test and measurement business segment under the Software and Control division. In the initial fiscal quarter, orders for this sector dropped by 17% compared to the preceding year, attributed to sustained softness in discrete and semiconductor markets, alongside continued challenges in China.

The company’s profitability has been impacted by escalating operational costs and expenditures. For example, in the first fiscal quarter, its cost of sales experienced a significant increase of 25.6% year over year, while selling, general, and administrative expenses saw a rise of 24%. Consequently, the pre-tax margin for the quarter decreased to 3.4%, down from 12.5% in the corresponding fiscal quarter of the previous year.